4 free views remaining today
pharynx carcinoma in situ
ICD-10 Codes
Related ICD-10:
Description
Pharynx Carcinoma in Situ (Stage 0): An Overview
Carcinoma in situ, also known as stage 0, is the earliest form of pharynx cancer. It is a condition where abnormal cells are found in the lining of the pharynx (throat), but they have not invaded deeper tissues or spread to other parts of the body.
Common Presentations
The most common symptoms of pharynx carcinoma in situ include:
- Persistent sore throat
- Dysphagia (difficulty swallowing)
- Odynophagia (painful swallowing)
- Dysarthria (speech difficulties)
- Presence of a lump in the neck
- Otalgia (ear pain)
Characteristics
In stage 0, the tumor is only present in the lining of the pharynx. It has not grown beyond this layer and has not invaded deeper tissues or spread to lymph nodes.
Staging
The staging system for oral cavity or oropharyngeal cancers ranges from I (1) through IV (4), with stage 0 being the earliest form. Stage 0 is also referred to as carcinoma in situ, which means that cancer cells are present but have not invaded deeper tissues.
Pre-Cancerous Condition
Stage 0 cancer or carcinoma in situ can be considered a pre-cancerous condition, where cancer cells are present but have not yet invaded deeper tissues. Some doctors prefer to call this "pre-cancer."
References:
- [2] The most common presentations include persistent sore throat, dysphagia, odynophagia, dysarthria, presence of a lump in the neck, and otalgia.
- [3] Stage 0 (also called carcinoma in situ of the oropharynx). In stage 0, abnormal cells are found in the lining of the oropharynx (throat).
- [8] Stage 0 cancer or carcinoma in situ (CIS) means your cancer is at a very early stage. Some doctors prefer to call this pre-cancer.
- [9] The earliest form of squamous cell cancer is called carcinoma in situ. This means that the cancer cells are only in the layer of cells called...
Additional Characteristics
- Dysphagia (difficulty swallowing)
- Carcinoma in situ, also known as stage 0
- Persistent sore throat
- Odynophagia (painful swallowing)
- Dysarthria (speech difficulties)
- Presence of a lump in the neck
- Otalgia (ear pain)
Signs and Symptoms
Pharyngeal carcinoma in situ, also known as stage 0 or carcinoma in situ, is a condition where abnormal cells are present in the pharynx (throat) but have not invaded deeper tissues. The signs and symptoms of this condition can be nonspecific and may vary from person to person.
Common symptoms:
- Sore throat [6]
- Dysphagia (difficulty swallowing) [2, 5, 6]
- Odynophagia (painful swallowing) [2, 5, 6]
- Presence of a lump in the neck is not typically associated with carcinoma in situ but rather more advanced stages [3]
Other possible symptoms:
- Chronic coughing
- Bloody phlegm
- Nosebleeds
- Frequent headaches and facial pain
It's essential to note that many people with early-stage pharyngeal carcinoma in situ may not experience any noticeable symptoms. If you're experiencing any of these symptoms, it's crucial to consult a healthcare professional for proper evaluation and diagnosis.
References: [1] Not applicable (this information is not present in the search results) [2] Context result 2 [3] Context result 3 [4] Not applicable (this information is not present in the search results) [5] Context result 5 [6] Context result 6
Additional Symptoms
- Sore throat
- Dysphagia (difficulty swallowing)
- Odynophagia (painful swallowing)
- Chronic coughing
- Bloody phlegm
- Nosebleeds
- Frequent headaches and facial pain
Diagnostic Tests
To diagnose carcinoma in situ (CIS) of the pharynx, several diagnostic tests can be employed.
- Physical exam: A thorough physical examination by a healthcare professional is often the first step in assessing the primary tumor. This includes inspection, palpation, and flexible laryngoscopy [6].
- Fiberoptic Laryngoscopy: A fiberoptic laryngoscopy may be performed to visualize the pharynx and identify any abnormalities [5].
- Biopsy: A biopsy involves collecting a tissue sample from the suspected cancer site. This is usually done under local anesthesia and can provide a definitive diagnosis [4, 5].
- Imaging tests: Additional imaging tests such as CT scans or MRI may be ordered to determine if there are any hidden tumors present in the pharynx due to its complex anatomy [8].
It's worth noting that the clinical stage of the cancer will also be used to help plan treatment, based on the results of a physical exam, endoscopy exam, biopsy, and imaging tests [9].
Additional Diagnostic Tests
- Biopsy
- Imaging tests
- Physical exam
- Fiberoptic Laryngoscopy
Treatment
Based on the provided context, it appears that there are various treatment options available for oropharyngeal cancer, which includes carcinoma in situ.
- Radiation therapy is mentioned as a potential treatment option in several search results ([1], [2], [3], and [4]). This suggests that radiation therapy may be considered for treating oropharyngeal cancer, including carcinoma in situ.
- Chemotherapy with radiation is also listed as a treatment option in some of the search results ([1], [2], and [3]). This implies that chemotherapy combined with radiation therapy may be used to treat oropharyngeal cancer, including carcinoma in situ.
- Targeted therapy is mentioned as another potential treatment option for oropharyngeal cancer ([1] and [7]). This suggests that targeted therapies may be explored for treating carcinoma in situ of the pharynx.
However, it's essential to note that the specific treatment approach would depend on various factors, including the stage and type of cancer, overall health, and personal preferences. A healthcare professional would need to evaluate these factors and provide personalized guidance on the most suitable treatment options.
In terms of drug treatment specifically for carcinoma in situ of the pharynx, there is limited information available in the provided context. However, it's worth noting that targeted therapies are being explored for treating various types of cancer, including oropharyngeal cancer ([1] and [7]).
If you're looking for more detailed information on drug treatment options for carcinoma in situ of the pharynx, I recommend consulting a healthcare professional or searching for recent medical studies and publications on this topic.
Recommended Medications
- Targeted therapy
- Radiation therapy
- Chemotherapy with radiation
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Pharynx Carcinoma In Situ
Carcinoma in situ (CIS) of the pharynx is a condition where abnormal cells that look like cancer cells under a microscope are found only in the place where they first formed and haven't spread to other parts of the body. The differential diagnosis for CIS of the pharynx includes several conditions that can mimic or be confused with CIS.
- Nasopharyngeal polyposis: This is a condition characterized by the growth of non-cancerous polyps in the nasopharynx, which can be mistaken for CIS.
- Angiofibromas: These are benign tumors that grow in the nasopharynx and can be confused with CIS due to their similar appearance under a microscope.
- Antro-choanal polyp: This is a type of non-cancerous growth that occurs in the nasal cavity and can be mistaken for CIS.
- Inverting papilloma: This is a type of benign tumor that grows in the nasopharynx and can be confused with CIS due to its similar appearance under a microscope.
- Adenoid hypertrophy: This is a condition where the adenoids become enlarged, which can be mistaken for CIS.
According to [1], differential diagnosis includes neuroendo- crine carcinoma (small cell and large cell types), SCC, adenoid cystic carcinoma (ACC), adenosqu- amous carcinoma.
It's essential to note that a proper diagnosis of CIS of the pharynx requires a thorough examination by an experienced healthcare professional, including a biopsy and histopathological examination.
References: [1] by DE Johnson · 2020 · Cited by 3013 — EBV-positive nasopharyngeal tumours​​
Additional Differential Diagnoses
- Nasopharyngeal polyposis
- Angiofibromas
- Antro-choanal polyp
- Inverting papilloma
- Neuroendocrine carcinoma (small cell and large cell types)
- adenoid hypertrophy
- adenoid cystic carcinoma
- squamous cell carcinoma
- adenosquamous carcinoma
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_649
- owl#annotatedSource
- t332563
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0050611
- core#notation
- DOID:0050611
- IAO_0000115
- An in situ carcinoma of the pharynx that is located_in the epithelium. It is associated with the development of squamous cell carcinoma.
- rdf-schema#label
- pharynx carcinoma in situ
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_8719
- relatedICD
- http://example.org/icd10/D00.08
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- owl#equivalentClass
- t332144
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.